nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CYP2E1—Dapsone—systemic lupus erythematosus	0.102	0.362	CbGbCtD
Methotrimeprazine—HTR2C—choroid plexus—systemic lupus erythematosus	0.0882	0.184	CbGeAlD
Methotrimeprazine—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0825	0.294	CbGbCtD
Methotrimeprazine—HTR2A—choroid plexus—systemic lupus erythematosus	0.0443	0.0921	CbGeAlD
Methotrimeprazine—CYP2E1—Dexamethasone—systemic lupus erythematosus	0.044	0.157	CbGbCtD
Methotrimeprazine—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0318	0.113	CbGbCtD
Methotrimeprazine—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.021	0.0746	CbGbCtD
Methotrimeprazine—CYP1A2—urine—systemic lupus erythematosus	0.0151	0.0315	CbGeAlD
Methotrimeprazine—CYP2E1—urine—systemic lupus erythematosus	0.0136	0.0284	CbGeAlD
Methotrimeprazine—HTR2A—urine—systemic lupus erythematosus	0.0118	0.0246	CbGeAlD
Methotrimeprazine—CYP2D6—urine—systemic lupus erythematosus	0.0108	0.0225	CbGeAlD
Methotrimeprazine—CHRM5—skin of body—systemic lupus erythematosus	0.00895	0.0186	CbGeAlD
Methotrimeprazine—DRD5—lymphoid tissue—systemic lupus erythematosus	0.00808	0.0168	CbGeAlD
Methotrimeprazine—CYP1A2—blood plasma—systemic lupus erythematosus	0.00791	0.0165	CbGeAlD
Methotrimeprazine—ADRA1B—kidney—systemic lupus erythematosus	0.00771	0.0161	CbGeAlD
Methotrimeprazine—ADRA2A—blood plasma—systemic lupus erythematosus	0.00727	0.0151	CbGeAlD
Methotrimeprazine—CYP2E1—blood plasma—systemic lupus erythematosus	0.00711	0.0148	CbGeAlD
Methotrimeprazine—CHRM4—nervous system—systemic lupus erythematosus	0.00709	0.0147	CbGeAlD
Methotrimeprazine—HTR2A—endothelium—systemic lupus erythematosus	0.00696	0.0145	CbGeAlD
Methotrimeprazine—CHRM4—central nervous system—systemic lupus erythematosus	0.00682	0.0142	CbGeAlD
Methotrimeprazine—DRD3—nervous system—systemic lupus erythematosus	0.00659	0.0137	CbGeAlD
Methotrimeprazine—DRD3—central nervous system—systemic lupus erythematosus	0.00634	0.0132	CbGeAlD
Methotrimeprazine—HTR2A—blood plasma—systemic lupus erythematosus	0.00618	0.0129	CbGeAlD
Methotrimeprazine—DRD5—nervous system—systemic lupus erythematosus	0.00617	0.0128	CbGeAlD
Methotrimeprazine—DRD5—central nervous system—systemic lupus erythematosus	0.00594	0.0124	CbGeAlD
Methotrimeprazine—CYP2D6—blood plasma—systemic lupus erythematosus	0.00563	0.0117	CbGeAlD
Methotrimeprazine—CHRM5—nervous system—systemic lupus erythematosus	0.00554	0.0115	CbGeAlD
Methotrimeprazine—CHRM5—central nervous system—systemic lupus erythematosus	0.00533	0.0111	CbGeAlD
Methotrimeprazine—ADRA1B—nervous system—systemic lupus erythematosus	0.00506	0.0105	CbGeAlD
Methotrimeprazine—ADRA1D—nervous system—systemic lupus erythematosus	0.00495	0.0103	CbGeAlD
Methotrimeprazine—ADRA1B—central nervous system—systemic lupus erythematosus	0.00487	0.0101	CbGeAlD
Methotrimeprazine—ADRA1D—central nervous system—systemic lupus erythematosus	0.00477	0.00992	CbGeAlD
Methotrimeprazine—CHRM3—kidney—systemic lupus erythematosus	0.00472	0.00982	CbGeAlD
Methotrimeprazine—DRD1—nervous system—systemic lupus erythematosus	0.00472	0.00982	CbGeAlD
Methotrimeprazine—ADRA2C—nephron tubule—systemic lupus erythematosus	0.0047	0.00978	CbGeAlD
Methotrimeprazine—DRD1—central nervous system—systemic lupus erythematosus	0.00454	0.00945	CbGeAlD
Methotrimeprazine—ADRA2C—kidney—systemic lupus erythematosus	0.00413	0.00859	CbGeAlD
Methotrimeprazine—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.00402	0.00837	CbGeAlD
Methotrimeprazine—HRH1—connective tissue—systemic lupus erythematosus	0.00394	0.0082	CbGeAlD
Methotrimeprazine—ADRA2A—connective tissue—systemic lupus erythematosus	0.00387	0.00805	CbGeAlD
Methotrimeprazine—CHRM2—nervous system—systemic lupus erythematosus	0.0038	0.00791	CbGeAlD
Methotrimeprazine—CHRM1—lung—systemic lupus erythematosus	0.00374	0.00778	CbGeAlD
Methotrimeprazine—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.00372	0.00775	CbGeAlD
Methotrimeprazine—CYP2E1—nephron tubule—systemic lupus erythematosus	0.00367	0.00763	CbGeAlD
Methotrimeprazine—HTR2C—nervous system—systemic lupus erythematosus	0.00366	0.00763	CbGeAlD
Methotrimeprazine—CHRM2—central nervous system—systemic lupus erythematosus	0.00366	0.00762	CbGeAlD
Methotrimeprazine—HTR2C—central nervous system—systemic lupus erythematosus	0.00353	0.00734	CbGeAlD
Methotrimeprazine—CHRM1—nervous system—systemic lupus erythematosus	0.00346	0.0072	CbGeAlD
Methotrimeprazine—ADRA2C—tendon—systemic lupus erythematosus	0.00333	0.00694	CbGeAlD
Methotrimeprazine—CHRM1—central nervous system—systemic lupus erythematosus	0.00333	0.00693	CbGeAlD
Methotrimeprazine—HTR2A—connective tissue—systemic lupus erythematosus	0.00329	0.00685	CbGeAlD
Methotrimeprazine—CYP2E1—kidney—systemic lupus erythematosus	0.00322	0.00671	CbGeAlD
Methotrimeprazine—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.00321	0.00668	CbGeAlD
Methotrimeprazine—CYP2E1—cortex of kidney—systemic lupus erythematosus	0.00314	0.00653	CbGeAlD
Methotrimeprazine—CHRM3—nervous system—systemic lupus erythematosus	0.0031	0.00644	CbGeAlD
Methotrimeprazine—DRD2—lung—systemic lupus erythematosus	0.00301	0.00626	CbGeAlD
Methotrimeprazine—CHRM3—central nervous system—systemic lupus erythematosus	0.00298	0.00621	CbGeAlD
Methotrimeprazine—ADRA2C—lung—systemic lupus erythematosus	0.00293	0.00609	CbGeAlD
Methotrimeprazine—ADRA1A—nervous system—systemic lupus erythematosus	0.00284	0.00592	CbGeAlD
Methotrimeprazine—HTR2A—kidney—systemic lupus erythematosus	0.0028	0.00583	CbGeAlD
Methotrimeprazine—DRD2—nervous system—systemic lupus erythematosus	0.00279	0.0058	CbGeAlD
Methotrimeprazine—CYP2E1—lymphoid tissue—systemic lupus erythematosus	0.00277	0.00576	CbGeAlD
Methotrimeprazine—ADRA1A—central nervous system—systemic lupus erythematosus	0.00274	0.0057	CbGeAlD
Methotrimeprazine—ADRA2C—nervous system—systemic lupus erythematosus	0.00271	0.00564	CbGeAlD
Methotrimeprazine—HRH1—tendon—systemic lupus erythematosus	0.00271	0.00564	CbGeAlD
Methotrimeprazine—DRD2—central nervous system—systemic lupus erythematosus	0.00268	0.00558	CbGeAlD
Methotrimeprazine—ADRA2A—tendon—systemic lupus erythematosus	0.00266	0.00554	CbGeAlD
Methotrimeprazine—ADRA2C—central nervous system—systemic lupus erythematosus	0.00261	0.00543	CbGeAlD
Methotrimeprazine—CYP2E1—tendon—systemic lupus erythematosus	0.0026	0.00542	CbGeAlD
Methotrimeprazine—CYP2D6—kidney—systemic lupus erythematosus	0.00255	0.00531	CbGeAlD
Methotrimeprazine—CYP1A2—lung—systemic lupus erythematosus	0.00254	0.00528	CbGeAlD
Methotrimeprazine—HRH1—lung—systemic lupus erythematosus	0.00238	0.00495	CbGeAlD
Methotrimeprazine—ADRA2A—lung—systemic lupus erythematosus	0.00233	0.00486	CbGeAlD
Methotrimeprazine—CYP2E1—lung—systemic lupus erythematosus	0.00228	0.00475	CbGeAlD
Methotrimeprazine—HTR2A—tendon—systemic lupus erythematosus	0.00226	0.00471	CbGeAlD
Methotrimeprazine—HRH1—nervous system—systemic lupus erythematosus	0.0022	0.00458	CbGeAlD
Methotrimeprazine—ADRA2A—nervous system—systemic lupus erythematosus	0.00216	0.0045	CbGeAlD
Methotrimeprazine—HRH1—central nervous system—systemic lupus erythematosus	0.00212	0.00441	CbGeAlD
Methotrimeprazine—CYP2E1—nervous system—systemic lupus erythematosus	0.00211	0.0044	CbGeAlD
Methotrimeprazine—ADRA2A—central nervous system—systemic lupus erythematosus	0.00208	0.00433	CbGeAlD
Methotrimeprazine—CYP2E1—central nervous system—systemic lupus erythematosus	0.00204	0.00424	CbGeAlD
Methotrimeprazine—HTR2A—lung—systemic lupus erythematosus	0.00199	0.00413	CbGeAlD
Methotrimeprazine—HTR2A—nervous system—systemic lupus erythematosus	0.00184	0.00383	CbGeAlD
Methotrimeprazine—HTR2A—central nervous system—systemic lupus erythematosus	0.00177	0.00368	CbGeAlD
Methotrimeprazine—CYP2D6—nervous system—systemic lupus erythematosus	0.00167	0.00349	CbGeAlD
Methotrimeprazine—CYP2D6—central nervous system—systemic lupus erythematosus	0.00161	0.00336	CbGeAlD
Methotrimeprazine—Liver injury—Azathioprine—systemic lupus erythematosus	0.000904	0.0519	CcSEcCtD
Methotrimeprazine—Liver injury—Leflunomide—systemic lupus erythematosus	0.000854	0.049	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Dapsone—systemic lupus erythematosus	0.000771	0.0442	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Azathioprine—systemic lupus erythematosus	0.000761	0.0437	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Leflunomide—systemic lupus erythematosus	0.000719	0.0412	CcSEcCtD
Methotrimeprazine—Liver injury—Cyclosporine—systemic lupus erythematosus	0.000659	0.0378	CcSEcCtD
Methotrimeprazine—Liver injury—Mycophenolate mofetil—systemic lupus erythematosus	0.000643	0.0369	CcSEcCtD
Methotrimeprazine—Sudden death—Methotrexate—systemic lupus erythematosus	0.000599	0.0344	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Cyclosporine—systemic lupus erythematosus	0.000555	0.0318	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Mycophenolate mofetil—systemic lupus erythematosus	0.000541	0.031	CcSEcCtD
Methotrimeprazine—Tachycardia—Dapsone—systemic lupus erythematosus	0.000469	0.0269	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Azathioprine—systemic lupus erythematosus	0.000397	0.0228	CcSEcCtD
Methotrimeprazine—Jaundice—Leflunomide—systemic lupus erythematosus	0.000392	0.0225	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Leflunomide—systemic lupus erythematosus	0.000375	0.0215	CcSEcCtD
Methotrimeprazine—Urinary retention—Mycophenolate mofetil—systemic lupus erythematosus	0.000373	0.0214	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000359	0.0206	CcSEcCtD
Methotrimeprazine—Weight increased—Cyclosporine—systemic lupus erythematosus	0.000317	0.0182	CcSEcCtD
Methotrimeprazine—Weight increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000309	0.0177	CcSEcCtD
Methotrimeprazine—Jaundice—Cyclosporine—systemic lupus erythematosus	0.000302	0.0174	CcSEcCtD
Methotrimeprazine—Jaundice—Mycophenolate mofetil—systemic lupus erythematosus	0.000295	0.0169	CcSEcCtD
Methotrimeprazine—Weight increased—Prednisolone—systemic lupus erythematosus	0.000288	0.0165	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000282	0.0162	CcSEcCtD
Methotrimeprazine—Weight increased—Hydrocortisone—systemic lupus erythematosus	0.000281	0.0161	CcSEcCtD
Methotrimeprazine—Weight increased—Triamcinolone—systemic lupus erythematosus	0.000265	0.0152	CcSEcCtD
Methotrimeprazine—Weight increased—Methylprednisolone—systemic lupus erythematosus	0.000264	0.0152	CcSEcCtD
Methotrimeprazine—Photosensitivity—Methotrexate—systemic lupus erythematosus	0.000253	0.0145	CcSEcCtD
Methotrimeprazine—Tachycardia—Leflunomide—systemic lupus erythematosus	0.00025	0.0144	CcSEcCtD
Methotrimeprazine—Weight increased—Betamethasone—systemic lupus erythematosus	0.00024	0.0138	CcSEcCtD
Methotrimeprazine—Weight increased—Dexamethasone—systemic lupus erythematosus	0.00024	0.0138	CcSEcCtD
Methotrimeprazine—Constipation—Leflunomide—systemic lupus erythematosus	0.000219	0.0126	CcSEcCtD
Methotrimeprazine—Weight increased—Prednisone—systemic lupus erythematosus	0.000209	0.012	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.0002	0.0115	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000189	0.0108	CcSEcCtD
Methotrimeprazine—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.0108	CcSEcCtD
Methotrimeprazine—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000176	0.0101	CcSEcCtD
Methotrimeprazine—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000176	0.0101	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Methotrexate—systemic lupus erythematosus	0.000176	0.0101	CcSEcCtD
Methotrimeprazine—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000172	0.00985	CcSEcCtD
Methotrimeprazine—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000172	0.00985	CcSEcCtD
Methotrimeprazine—Drowsiness—Methotrexate—systemic lupus erythematosus	0.000171	0.00984	CcSEcCtD
Methotrimeprazine—Constipation—Cyclosporine—systemic lupus erythematosus	0.000169	0.00971	CcSEcCtD
Methotrimeprazine—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000165	0.00947	CcSEcCtD
Methotrimeprazine—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000162	0.00927	CcSEcCtD
Methotrimeprazine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000161	0.00925	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.00016	0.00918	CcSEcCtD
Methotrimeprazine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000147	0.00841	CcSEcCtD
Methotrimeprazine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000147	0.00841	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000146	0.00837	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000142	0.00816	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000133	0.00761	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.00013	0.00743	CcSEcCtD
Methotrimeprazine—Tachycardia—Prednisone—systemic lupus erythematosus	0.000128	0.00733	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000122	0.007	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000122	0.00698	CcSEcCtD
Methotrimeprazine—Constipation—Prednisone—systemic lupus erythematosus	0.000112	0.00642	CcSEcCtD
Methotrimeprazine—Somnolence—Methotrexate—systemic lupus erythematosus	9.72e-05	0.00558	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Prednisone—systemic lupus erythematosus	9.64e-05	0.00553	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	8.06e-05	0.00462	CcSEcCtD
Methotrimeprazine—ADRA1B—Signaling Pathways—CD80—systemic lupus erythematosus	3.26e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NOS3—systemic lupus erythematosus	3.25e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NOS3—systemic lupus erythematosus	3.25e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.22e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	3.2e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	3.2e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	3.19e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.17e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CCL2—systemic lupus erythematosus	3.16e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—F2—systemic lupus erythematosus	3.13e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.13e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL2—systemic lupus erythematosus	3.1e-05	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	3.1e-05	0.00014	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—IL6—systemic lupus erythematosus	3.09e-05	0.00014	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	3.08e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CCL2—systemic lupus erythematosus	3.08e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—F2—systemic lupus erythematosus	3.08e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—F2—systemic lupus erythematosus	3.07e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL2—systemic lupus erythematosus	3.06e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—F2—systemic lupus erythematosus	3.06e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—IL6—systemic lupus erythematosus	3.05e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—ALB—systemic lupus erythematosus	3.03e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	3.03e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—F2—systemic lupus erythematosus	3.03e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.02e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	3.02e-05	0.000137	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	3e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—systemic lupus erythematosus	3e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	2.99e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	2.95e-05	0.000134	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CD80—systemic lupus erythematosus	2.95e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CD80—systemic lupus erythematosus	2.94e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MMP9—systemic lupus erythematosus	2.94e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	2.94e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL2—systemic lupus erythematosus	2.93e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CD80—systemic lupus erythematosus	2.93e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.93e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—IL6—systemic lupus erythematosus	2.92e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—NOS3—systemic lupus erythematosus	2.9e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CD80—systemic lupus erythematosus	2.9e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MMP9—systemic lupus erythematosus	2.9e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	2.89e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.89e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	2.87e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.85e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PPARG—systemic lupus erythematosus	2.84e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	2.82e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.82e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.82e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	2.8e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	2.79e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL2—systemic lupus erythematosus	2.79e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	2.79e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	2.78e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—EP300—systemic lupus erythematosus	2.78e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	2.78e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MMP9—systemic lupus erythematosus	2.77e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.76e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL2—systemic lupus erythematosus	2.76e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL2—systemic lupus erythematosus	2.76e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	2.75e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—EP300—systemic lupus erythematosus	2.75e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.75e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL6—systemic lupus erythematosus	2.74e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL6—systemic lupus erythematosus	2.74e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	2.74e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.74e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.73e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCL2—systemic lupus erythematosus	2.72e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	2.71e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	2.7e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCL2—systemic lupus erythematosus	2.7e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.69e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	2.69e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	2.66e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—systemic lupus erythematosus	2.65e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.64e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.64e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.63e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—EP300—systemic lupus erythematosus	2.63e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MMP9—systemic lupus erythematosus	2.61e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MMP9—systemic lupus erythematosus	2.61e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.6e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.6e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.6e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—ALB—systemic lupus erythematosus	2.56e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.54e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	2.53e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.51e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EP300—systemic lupus erythematosus	2.51e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.5e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	2.49e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.49e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.49e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.49e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	2.49e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	2.49e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.48e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	2.48e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EP300—systemic lupus erythematosus	2.47e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EP300—systemic lupus erythematosus	2.47e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TYK2—systemic lupus erythematosus	2.47e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL6—systemic lupus erythematosus	2.47e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TYK2—systemic lupus erythematosus	2.45e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.45e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—NOS3—systemic lupus erythematosus	2.45e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.44e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.44e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.44e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	2.44e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.44e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NOS3—systemic lupus erythematosus	2.43e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.42e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NOS3—systemic lupus erythematosus	2.4e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.4e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	2.39e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.39e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	2.38e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.38e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.37e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	2.36e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.35e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.34e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.34e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.34e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	2.32e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	2.31e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	2.29e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.29e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	2.28e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.27e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	2.26e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.25e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—systemic lupus erythematosus	2.24e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	2.23e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.23e-05	0.000101	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—EP300—systemic lupus erythematosus	2.21e-05	9.99e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	2.2e-05	9.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.19e-05	9.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.18e-05	9.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	2.17e-05	9.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.16e-05	9.76e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.16e-05	9.75e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.15e-05	9.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.15e-05	9.73e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	2.14e-05	9.7e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.12e-05	9.59e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.12e-05	9.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.11e-05	9.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.11e-05	9.54e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	2.11e-05	9.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.1e-05	9.51e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	2.1e-05	9.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	2.09e-05	9.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.08e-05	9.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.08e-05	9.39e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	2.08e-05	9.39e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL2—systemic lupus erythematosus	2.07e-05	9.37e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.06e-05	9.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL2—systemic lupus erythematosus	2.06e-05	9.34e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—systemic lupus erythematosus	2.06e-05	9.32e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL2—systemic lupus erythematosus	2.06e-05	9.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	2.05e-05	9.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	2.05e-05	9.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—systemic lupus erythematosus	2.05e-05	9.26e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL2—systemic lupus erythematosus	2.04e-05	9.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	2.03e-05	9.19e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.03e-05	9.19e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—systemic lupus erythematosus	2.03e-05	9.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	2.03e-05	9.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.02e-05	9.15e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	2.02e-05	9.13e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	2e-05	9.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.99e-05	9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.98e-05	8.94e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.96e-05	8.89e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.96e-05	8.87e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.96e-05	8.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.95e-05	8.84e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.95e-05	8.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.95e-05	8.81e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.95e-05	8.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.94e-05	8.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.94e-05	8.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.94e-05	8.78e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.93e-05	8.73e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.93e-05	8.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.92e-05	8.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.92e-05	8.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.92e-05	8.67e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	1.89e-05	8.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.89e-05	8.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.88e-05	8.5e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.86e-05	8.43e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.86e-05	8.42e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—EP300—systemic lupus erythematosus	1.86e-05	8.42e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EP300—systemic lupus erythematosus	1.86e-05	8.41e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EP300—systemic lupus erythematosus	1.85e-05	8.38e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EP300—systemic lupus erythematosus	1.85e-05	8.35e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EP300—systemic lupus erythematosus	1.83e-05	8.27e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—systemic lupus erythematosus	1.82e-05	8.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.82e-05	8.25e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.81e-05	8.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.81e-05	8.2e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—systemic lupus erythematosus	1.8e-05	8.14e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.79e-05	8.11e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.79e-05	8.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.78e-05	8.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.78e-05	8.05e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.76e-05	7.98e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.76e-05	7.96e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.75e-05	7.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.75e-05	7.91e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.74e-05	7.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.73e-05	7.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.73e-05	7.81e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—systemic lupus erythematosus	1.72e-05	7.8e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.71e-05	7.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.69e-05	7.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.65e-05	7.44e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—systemic lupus erythematosus	1.64e-05	7.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—systemic lupus erythematosus	1.62e-05	7.33e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—systemic lupus erythematosus	1.62e-05	7.33e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.62e-05	7.32e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.62e-05	7.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.61e-05	7.28e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.61e-05	7.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.6e-05	7.26e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.59e-05	7.19e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.59e-05	7.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.59e-05	7.17e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.54e-05	6.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.47e-05	6.66e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.47e-05	6.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	1.46e-05	6.62e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	1.4e-05	6.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	1.37e-05	6.18e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.34e-05	6.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	1.34e-05	6.08e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.32e-05	5.97e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	1.24e-05	5.61e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.22e-05	5.52e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—systemic lupus erythematosus	1.22e-05	5.51e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—systemic lupus erythematosus	1.21e-05	5.49e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—systemic lupus erythematosus	1.21e-05	5.47e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—systemic lupus erythematosus	1.2e-05	5.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	1.19e-05	5.4e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.12e-05	5.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.11e-05	5.02e-05	CbGpPWpGaD
